Vitamin D API Manufacturers

compare suppliers & get competitive offers

Pharmaoffer_donkere_achtergrond
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Vitamin D is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Vitamin D or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Vitamin D API 1406-16-2?

Description:
Here you will find a list of producers, manufacturers and distributors of Vitamin D. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Vitamin D 
Synonyms:
Calciferol , Vitamin D NOS , Vitamin D, unspecified form  
Cas Number:
1406-16-2 
DrugBank number:
DB11094 
Unique Ingredient Identifier:
9VU1KI44GP

General Description:

Vitamin D, identified by CAS number 1406-16-2, is a notable compound with significant therapeutic applications. Vitamin D ultimately comprises a group of lipid-soluble secosteroids responsible for a variety of biological effects, some of which include increasing the intestinal absorption of calcium, magnesium, and phosphate. With reference to human use, there are 2 main forms of vitamin D - vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol). When non-specific references are made about 'vitamin d', the references are usually about the use of vitamin D3 and/or D2. Vitamin D3 and D2 require hydroxylation in order to become biologically active in the human body. Since vitamin D can be endogenously synthesized in adequate amounts by most mammals exposed to sufficient quantities of sunlight, vitamin D functions like a hormone on vitamin D receptors to regulate calcium in opposition to parathyroid hormone. Vitamin D plays an essential physiological role in maintaining calcium homeostasis and metabolism. There are several different vitamin D supplements that are given to treat or to prevent osteomalacia and rickets, or to meet the daily criteria of vitamin D consumption.

Indications:

This drug is primarily indicated for: Vitamin D is indicated for use in the treatment of hypoparathyroidism, refractory rickets (also known as vitamin D resistant rickets), and familial hypophosphatemia . Its use in specific medical scenarios underscores its importance in the therapeutic landscape.

Metabolism:

Vitamin D undergoes metabolic processing primarily in: In the liver, vitamin D3 and D2 are hydroxylated to calcidiol (25-hydroxycholecalciferol) and ercalcidiol (25-hydroxyergocalciferol) , respectively, by the enzyme 25-hydroxylase. At the level of the kidney, calcidiol and ercalcidiol are hydroxylated to yield calcitriol (1,25-dihydroxycholecalciferol) and ercalcitriol (1,25-dihydroxyergocalciferol) , the primary biologically active forms of vitamin D3 and D2 respectively, by the enzyme 1-alpha-hydroxylase. This metabolic pathway ensures efficient processing of the drug, helping to minimize potential toxicity and side effects.

Absorption:

The absorption characteristics of Vitamin D are crucial for its therapeutic efficacy: Vitamin D3 and D2 are readily absorbed from the small intestine (proximal or distal) . The drug's ability to rapidly penetrate into cells ensures quick onset of action.

Half-life:

The half-life of Vitamin D is an important consideration for its dosing schedule: Although certain studies suggest the half-life of 1,25-hydroxyvitamin D3 may be approximately 15 hours, the half-life of 25-hydroxyvitamin D3 appears to have a half-life of about 15 days . Intriguingly however, the half-lives of any particular administration of vitamin d can vary and in general the half-lives of vitamin D2 metabolites have been demonstrated to be shorter overall than vitamin D3 half-lives with this being affected by vitamin d binding protein concentrations and genotype in particular individuals . This determines the duration of action and helps in formulating effective dosing regimens.

Protein Binding:

Vitamin D exhibits a strong affinity for binding with plasma proteins: Some studies suggest vitamin D3 demonstrates protein binding of 50-80% while others discuss vitamin D2 having >99.8% protein binding . This property plays a key role in the drug's pharmacokinetics and distribution within the body.

Route of Elimination:

The elimination of Vitamin D from the body primarily occurs through: The primary excretion route of vitamin D is via the bile into the feces . Understanding this pathway is essential for assessing potential drug accumulation and toxicity risks.

Clearance:

The clearance rate of Vitamin D is a critical factor in determining its safe and effective dosage: Some studies propose an estimated clearance rate for 1,25-dihydroxyvitamin D as 31 +/- 4 ml/min in healthy adults . It reflects the efficiency with which the drug is removed from the systemic circulation.

Pharmacodynamics:

Vitamin D exerts its therapeutic effects through: The in vivo synthesis of the predominant two biologically active metabolites of vitamin D occurs in two steps. The first hydroxylation of vitamin D3 or D2 occurs in the liver to yield 25-hydroxyvitamin D while the second hydroxylation happens in the kidneys to give 1, 25-dihydroxyvitamin D . These vitamin D metabolites subsequently facilitate the active absorption of calcium and phosphorus in the small intestine, serving to increase serum calcium and phosphate levels sufficiently to allow bone mineralization . Conversely, these vitamin D metabolites also assist in mobilizing calcium and phosphate from bone and likely increase the reabsorption of calcium and perhaps also of phosphate via the renal tubules . There exists a period of 10 to 24 hours between the administration of vitamin D and the initiation of its action in the body due to the necessity of synthesis of the active vitamin D metabolites in the liver and kidneys . It is parathyroid hormone that is responsible for the regulation of such metabolism at the level of the kidneys . The drug's ability to modulate various physiological processes underscores its efficacy in treating specific conditions.

Mechanism of Action:

Vitamin D functions by: Most individuals naturally generate adequate amounts of vitamin D through ordinary dietary intake of vitamin D (in some foods like eggs, fish, and cheese) and natural photochemical conversion of the vitamin D3 precursor 7-dehydrocholesterol in the skin via exposure to sunlight. Conversely, vitamin D deficiency can often occur from a combination of insufficient exposure to sunlight, inadequate dietary intake of vitamin D, genetic defects with endogenous vitamin D receptor, or even severe liver or kidney disease . Such deficiency is known for resulting in conditions like rickets or osteomalacia, all of which reflect inadequate mineralization of bone, enhanced compensatory skeletal demineralization, resultant decreased calcium ion blood concentrations, and increases in the production and secretion of parathyroid hormone . Increases in parathyroid hormone stimulates the mobilization of skeletal calcium and the renal excretion of phosphorus . This enhanced mobilization of skeletal calcium leads towards porotic bone conditions . Ordinarily, while vitamin D3 is made naturally via photochemical processes in the skin, both itself and vitamin D2 can be found in various food and pharmaceutical sources as dietary supplements. The principal biological function of vitamin D is the maintenance of normal levels of serum calcium and phosphorus in the bloodstream by enhancing the efficacy of the small intestine to absorb these minerals from the diet . At the liver, vitamin D3 or D2 is hydroxylated to 25-hydroxyvitamin D and then finally to the primary active metabolite 1,25-dihydroxyvitamin D in the kidney via further hydroxylation . This final metabolite binds to endogenous vitamin d receptors, which results in a variety of regulatory roles - including maintaining calcium balance, the regulation of parathyroid hormone, the promotion of the renal reabsorption of calcium, increased intestinal absorption of calcium and phosphorus, and increased calcium and phosphorus mobilization of calcium and phosphorus from bone to plasma to maintain balanced levels of each in bone and the plasma . This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.

Toxicity:

Categories:

Vitamin D is categorized under the following therapeutic classes: Bone Density Conservation Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Diet, Food, and Nutrition, Food, Fused-Ring Compounds, Micronutrients, Physiological Phenomena, Secosteroids, Steroids, Vitamin D and Analogues, Vitamins, Vitamins (Fat Soluble). These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.

Vitamin D is a type of Vitamin D analogues


Vitamin D analogues belong to the pharmaceutical category of active pharmaceutical ingredients (APIs) and are widely used in the medical field. These analogues are synthetic compounds designed to mimic the effects of natural vitamin D, a vital nutrient for human health. Vitamin D plays a crucial role in maintaining proper bone health, regulating calcium and phosphorus levels, and supporting the immune system.

Pharmaceutical companies produce various types of vitamin D analogues, each with distinct properties and applications. These analogues are designed to target specific receptors in the body, mimicking the actions of natural vitamin D. By interacting with these receptors, vitamin D analogues can effectively regulate calcium absorption and metabolism, promoting optimal bone health.

One of the significant advantages of using vitamin D analogues as APIs is their enhanced stability and bioavailability compared to natural vitamin D. This allows for better control over dosage and ensures consistent therapeutic effects. Moreover, pharmaceutical-grade analogues undergo rigorous quality control measures to guarantee their purity, safety, and efficacy.

Medical professionals prescribe vitamin D analogues to patients with vitamin D deficiencies, osteoporosis, psoriasis, and other related conditions. These APIs are available in various formulations, including oral tablets, capsules, and topical creams, allowing for flexible and convenient administration.

In summary, vitamin D analogues are a vital category of pharmaceutical APIs widely used to address vitamin D deficiencies and related health conditions. Their synthetic nature, enhanced stability, and targeted actions make them an effective option for maintaining bone health and supporting overall well-being.